Y Intercept (Hong Kong) LTD Acumen Pharmaceuticals, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 250,848 shares of ABOS stock, worth $316,068. This represents 0.01% of its overall portfolio holdings.
Number of Shares
250,848Holding current value
$316,068% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding ABOS
# of Institutions
72Shares Held
38.8MCall Options Held
31.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA14.9MShares$18.8 Million0.38% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.31 Million1.28% of portfolio
-
Franklin Resources Inc San Mateo, CA3.08MShares$3.88 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.72 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.95MShares$2.46 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $51M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...